SCHEMBL28397707

SCHEMBL28397707

CC(C)(C)[Si](C)(C)O[C@@H](O)Cc1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.47
CYP3A4 P08684 2/20 0.41
IDO1 P14902 2/20 0.41
AGXT P21549 2/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.41
CTSL P07711 1/20 0.39
RIPK1 Q13546 1/20 0.37
SLC16A3 O15427 1/20 0.37
MCTS1 Q9ULC4 1/20 0.37
TAAR1 Q96RJ0 4/20 0.36
HTR3E A5X5Y0 2/20 0.36
HTR3B O95264 2/20 0.36
HTR3A P46098 2/20 0.36
HTR3D Q70Z44 2/20 0.36
HTR3C Q8WXA8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29034722 0.83 PNMT (0.55) PNMTCYP3A4IDO1AGXTCTSL
SCHEMBL9621418 0.82 TRPA1 (0.40) TAAR1
SCHEMBL21367138 0.77 CYP3A4 (0.56) PNMTCYP3A4IDO1AGXTTAAR1
SCHEMBL6203638 0.77 PNMT (0.58) PNMTCYP3A4IDO1AGXTTSHR
SCHEMBL16798290 0.74 CTSL (0.42) PNMTCTSLRIPK1SLC16A3MCTS1
SCHEMBL9063602 0.72 AOC3 (0.43) IDO1
SCHEMBL15413373 0.72 TAAR1 (0.46) PNMTCYP3A4IDO1AGXTTAAR1
SCHEMBL24628719 0.71 TAAR1 (0.42) IDO1AGXTTAAR1
SCHEMBL19415420 0.71 CYP2B6 (0.36) ALDH1A1
SCHEMBL2427261 0.71 PNMT (0.69) PNMTCYP3A4IDO1AGXTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638917-A Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compounds, and methods of use thereof 捷思英达控股有限公司 2021-04-09 CN disclosed
CN-111032656-A Heterocyclic compound kinase inhibitor and pharmaceutical composition and application thereof 捷思英达医药技术(上海)有限公司 2020-04-17 CN disclosed